IFN‐γ‐STAT1 is an important pathway for anti‐tumor immunity after immune infiltration, and the inhibition of its pathway may limit the potential of IL6RIL6 as an mRNA vaccine intratumoral injection for melanoma treatment. Here, STAT1 is linked to melanoma.